Specifically, Zhu et al. demonstrated that in gastric carcinogenesis, IL-33, via the ST2 receptor, activates the TRAF6/PI3K/Akt/NF-κB pathway, thereby triggering the subsequent VEGFA-induced angiogenesis, which provides blood supply and nutrients for tumor formation 77. Here, IL33 is linked to neoplasm.